SlideShare a Scribd company logo
1 of 23
Download to read offline
The Frank R. Lautenberg
Chemical Safety for the
21st Century Act
Overview
June 2016
The New Law
• The “Frank R. Lautenberg Chemical Safety
for the 21st Century Act” was signed by
the President and went into effect
on June 22, 2016
• Amends and updates the Toxic
Substances Control Act of 1976
• Passed by large bipartisan margins in the
U.S. House and Senate
• Received broad stakeholder support
2
Major Improvements Over Current Law
• Mandatory duty on EPA to evaluate existing
chemicals with clear and enforceable deadlines
– Old TSCA – no duty to review; no deadlines for action
• Chemicals assessed against a risk-based safety
standard
– Old TSCA – risk-benefit balancing standard
• Unreasonable risks identified in the risk
evaluation must be eliminated
– Old TSCA – Signficant risks might not be addressed
due to cost/benefit balancing and no mandate to act
• Expanded authority to more quickly require
development of chemical information when
needed
– Old TSCA – Required lengthy rulemaking 3
Major Improvements Over Current Law
• Requires EPA to make an affirmative
determination on new chemicals before entry
into the marketplace
– Old TSCA – new chemicals enter the market in the
absence of EPA action
• Requires substantiation of certain CBI claims
– Old TSCA – no statutory substantiation requirements for
CBI claims
• New funding source (up to $25 million total in
annual user fees), to be supplemented by
Congressional appropriations
– Old TSCA – Cap on individual user fees at $2,500, and
limited fee collection authority
4
New Chemicals
• New law requires EPA to make affirmative finding on new
chemicals or significant new uses of existing chemicals
• Before the chemical can enter the market, EPA must find
that the chemical:
– “presents an unreasonable risk” and issue a 5(f) order to
address such risk;
– “information…is insufficient to permit a reasoned
evaluation…” and issue a 5(e) order;
– “may present an unreasonable risk” and issue a 5(e) order;
or
– is “not likely to present an unreasonable risk” and publish
the determination
• New law effectively resets 90-day clock for reviews
underway but EPA is working to complete reviews & make
determinations within the original review period.
5
Specific Requirements
Existing Chemicals
• Prioritizing Chemicals for Assessment
– Establish a risk-based process to identify “high”
and “low” priority substances
– High priority – the chemical may present an
unreasonable risk of injury to health or the
environment due to potential hazard and route of
exposure, including to susceptible subpopulations
– Low priority – the chemical use does not meet the
standard for high-priority
 Procedural rule required by June 2017 to establish process
for prioritizing chemicals
o Interim milestone – proposed rule mid-December 2016
6
Specific Requirements
Existing Chemicals
• Risk Evaluation
– “High priority” designation triggers
mandatory risk evaluation to be completed in
3 years, with possible 6 month extension
– For each risk evaluation completed, EPA must
designate a new high priority chemical
– Within 3.5 years, EPA must have 20 ongoing
chemical risk evaluations
 Procedural rule required by June 2017 to establish
process for evaluating the risks of high priority
chemicals
o Interim Milestone – Proposed rule mid-December 2016
7
Specific Requirements
Existing Chemicals
• Initial Set of Work Plan Chemical Assessments
– Identify a list of 10 TSCA Work Plan chemicals
and formally initiate risk evaluations by mid-
December 2016
– Release the scope of each assessment by mid-
June 2017
8
Specific Requirements
Existing Chemicals
• Risk-Based Safety Standard
– Chemicals are evaluated against a new risk-based safety
standard to determine whether a chemical use poses an
“unreasonable risk”
• The risk determination is to be made without consideration of
costs or other non-risk factors
– Risks to susceptible and highly exposed populations
must be considered
– EPA must take risk management action to address
unreasonable risks
• Costs and availability of alternatives to be considered when
selecting among risk management options
• Exemption process for critical uses
• Risk management actions must be promulgated within 2 years of
completing risk evaluation, with extension of up to two additional
years 9
Specific Requirements
Existing Chemicals
• Manufacturer-Requested Assessment
– Establishes a process for manufacturers to request that EPA
evaluate specific chemicals, and pay costs as follows:
• For chemicals on the TSCA Workplan, manufacturers pay
50% of costs; and
• For all other chemicals, manufacturers pay 100% of costs
• Manufacturer requests subject to the following
limitations:
– Granted at the Administrator’s discretion
– Do not count toward the 20 risk evaluations EPA must have
underway
– Must be a minimum of 25% of ongoing reviews but no more
than 50%
• E.g., if EPA is evaluating 20 high priority chemicals, there could
be an additional 5 to 10 industry petitioned evaluations
proceeding in parallel
10
Specific Requirements
Existing Chemicals
• Persistent, Bioaccumulative and Toxic Chemicals
– The new law establishes fast-track process to address
certain PBT chemicals already on TSCA Workplan
– No risk evaluation; only a use and exposure assessment
– Rules to reduce exposure to the extent practable must
be proposed within 3 years of enactment and finalized
18 months later, unless a manufacturer requests a risk
evaluation by Sept. 22, 2016
– Additional requirements encourage prioritization of
PBTs in overall risk evaluation process
11
Existing Chemicals
• TSCA Inventory
– Requires industry to report on the chemicals
they manufactured or processed in previous
10 years to determine if chemicals are
currently “active” in the marketplace
– The chemicals on the TSCA Inventory will not
change
– Chemicals will be designated as “active” or
“inactive”
– Only “active” chemcials may be prioritized
– No PMN required to move from “inactive” to
“active”
12
Existing Chemicals FlowChart
13
Specific Requirements
Existing Chemicals
• Ongoing Risk Management Rulemakings
– For chemical uses with completed risk
assessments showing unreasonable risk before
June 22, 2016, Section 26 allows EPA to propose
and issue final Section 6 rules consistent with
those assessments
– EPA anticipates issuing the following rules:
• TCE use in spot cleaning and aerosol degreasing
• TCE use in vapor degreasing
• Methylene chloride (MC) and N-methylpyrrolidone
(NMP) in paint removers
14
Testing Authority
• Provides authority to issue orders to require
testing when necessary for prioritizing a chemical
or conducting a risk evaluation, in addition to
rulemaking
• Requires development of strategic plan for
promoting the development and implementation
of alternative (non-animal) testing methodologies
and protocols
15
Confidential Business Information
• New requirements for Confidential Business
Information (CBI) will provide greater public
access to critical chemical information
– Manufacturers must substantiate certain CBI claims
including those for chemical identity (Chem ID) for
existing chemicals
• All CBI claims sunset after ten years unless reasserted by the
company
– For new CBI claims, EPA must:
• Affirmatively review all chem ID CBI claims
• Screen a subset of non-chem ID CBI claims (25%)
– For past CBI claims, EPA must:
• Retrospectively review past chem ID claims to determine if
claims are adequately substantiated.
16
Source of Funding
• Provides authority to collect fees from
manufacturers and processors who:
– Are required to submit test data;
– Submit notification of intent to manufacture a new
chemical or new use of a chemical;
– Manufacture or process a chemical substance that is
subject to a risk evaluation; or
– Request EPA to conduct risk evaluation on an existing
chemical;
• General fee amounts:
– EPA can set fees amounts to defray 25% of program
implementation costs
– Subject to annual cap of $25 million
 Goal – Engage stakeholders and publish proposed rule by
mid-December and final rule mid-June 2017
17
State-Federal Partnership
• Preservation of State Laws
– Bill preserves state authority to act on chemical
risks not acted on by EPA.
– If EPA does act, the following State actions are
preserved:
• Actions taken before April 2016
• The implementation of other environmental laws
(air, water, waste treatment, disposal, reporting,
monitoring, etc.)
• Co-enforcement of identical requirements and
penalties that do not exceed the federal maximum
• Actions on chemicals identified as low-priority by
EPA
18
State-Federal Partnership
• Preemption of State Laws
– If EPA’s assessment indicates that a chemical is safe, State
provisions are preempted
– If EPA takes final action to address a chemical’s risks, State
provisions are preempted,
– State Significant New Use Rules preempted if EPA imposes a
comparable requirement, unless waivers or exceptions are
identified.
• New State action is “paused” during EPA’s risk
evaluation of high priority chemicals
– If EPA misses deadline for the risk evaluation, pause is lifted
– If risks identified, pause is lifted and states could put new
provisions in place but would be preempted on effective date
of EPA’s final risk management rule
– If EPA determines chemical is safe, preemption continues
19
State-Federal Partnership
• State Waivers for Preemption
– States can apply to EPA for a waiver from general or pause
preemption.
– EPA must grant an exemption from pause preemption if:
• State has enacted a statute, or proposed or finalized an
administrative action, to prohibit or restrict a chemical, or
• State provision meets certain criteria
– EPA may grant an exemption from general preemption,
through rulemaking, if specific criteria are met, including:
• “Compelling conditions” that necessitate the waiver;
• No undue burden on interstate commerce; and
• EPA support for the State’s scientific judgment of the risk, based
on best available science and weight of evidence
– If EPA fails to make a decision on a state waiver within 110 day
review period, the waiver is automatically granted
– EPA’s grant of an exemption can be challenged in court.
20
Other Actions
• Mercury
– Adds mercury compounds to export ban of
elemental mercury
• Publish initial list of prohibited compounds by mid-Sep
– Requires that EPA publish an inventory of mercury
supply, use and trade in the US
• Publish by April 1, 2017 and update every 3 years
• Annual Report to Congress
• Review Small Business definition within 180 days
• Establish a Scientific Advisory Committee by June
2017
21
Key Milestones
New
Chemicals
Existing Chemicals Inventory /
Nomenclature
CBI Other Fees
Day 1 Implement
for all
- §6 rules under development will
address new standards
- Risk Assessments – will address
new standards
- Review CBI claims for
chem ID w/in 90 days
6 Months -Publish List of 10 Risk
Assessments underway for WP
Chemicals
-January 1st of each year –
updated plan for Risk Evaluations
** Proposed rule – prioritization
and evaluation
Proposed rule –
Active/Inactive
-Determine whether
review small business
definition warranted
-Report to Congress on
Capacity to Implement
**Proposed Rule
1 Year -Final Rule: Prioritization Process
-Final Rule: Risk Evaluation
Process (including guidance for
manufacturer requests)
- Publish scope of first 10 risk
evaluations
-Final Rule:
Active/Inactive
--Establish SACC **Final Rule
2 Year -Negotiated Proposed Rule –
Byproduct Reporting
-2½ years: Get
active/inactive
reports
-Rules re: CBI
substantiation – 2.5
years
-Guidance re: generic
names
-Strategic Plan: Promote
Alternative Test
Methods
-All policies, procedures,
guidance needed
3 Year -3½ years -- 20 Risk Assessments
underway (1/2 from WP, min)
-20 Low Priorities identified
-Proposed Rule – WorkPlan PBTs
-Final Rule: Byproducts
-3½ years: Rule to
establish plan for
reviewing all CBI claims
for active chemical IDs
5 Year -4 ½ years – Final Rule: PBTs -Complete review of
CBI claims for all active
ChemIDs
-Report to Congress re:
implementation of plan
re: Alternative Methods
**Not a
statutory
deadline
22
For More Information:
https://www.epa.gov/assessing-and-managing-chemicals-
under-tsca/frank-r-lautenberg-chemical-safety-21st-
century-act
Contact EPA at:
https://www.epa.gov/assessing-and-managing-chemicals-
under-tsca/forms/assessing-and-managing-chemicals-
under-tsca
23

More Related Content

What's hot

Global Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IURGlobal Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IURJSibblies
 
Regulatory Briefing | Overview of REACH Directive | Caltha LLP
Regulatory Briefing | Overview of REACH Directive | Caltha LLPRegulatory Briefing | Overview of REACH Directive | Caltha LLP
Regulatory Briefing | Overview of REACH Directive | Caltha LLPLoren Larson, CHMM, CSO, CEI
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramTGA Australia
 
Encamp: EPCRA Master Class - November 10 2021
Encamp: EPCRA Master Class - November 10 2021Encamp: EPCRA Master Class - November 10 2021
Encamp: EPCRA Master Class - November 10 2021Encamp1
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...TGA Australia
 

What's hot (11)

Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management ForumJim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
 
Global Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IURGlobal Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IUR
 
Regulatory Briefing | Overview of REACH Directive | Caltha LLP
Regulatory Briefing | Overview of REACH Directive | Caltha LLPRegulatory Briefing | Overview of REACH Directive | Caltha LLP
Regulatory Briefing | Overview of REACH Directive | Caltha LLP
 
HCF 2019 Panel 1: Tala Henry
HCF 2019 Panel 1: Tala HenryHCF 2019 Panel 1: Tala Henry
HCF 2019 Panel 1: Tala Henry
 
June 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim JonesJune 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim Jones
 
HCF 2106: Kenan Stevick
HCF 2106: Kenan StevickHCF 2106: Kenan Stevick
HCF 2106: Kenan Stevick
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
 
March 2020 Can Fite presentation
March 2020 Can Fite presentationMarch 2020 Can Fite presentation
March 2020 Can Fite presentation
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection Program
 
Encamp: EPCRA Master Class - November 10 2021
Encamp: EPCRA Master Class - November 10 2021Encamp: EPCRA Master Class - November 10 2021
Encamp: EPCRA Master Class - November 10 2021
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...
 

Similar to The Frank R. Lautenberg Chemical Safety for the 21st Century Act

Prescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsPrescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsTGA Australia
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016TGA Australia
 
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?Canadian Cancer Survivor Network
 
Presentation: Earlier access to medicines and medical technologies and the MMDR
Presentation: Earlier access to medicines and medical technologies and the MMDRPresentation: Earlier access to medicines and medical technologies and the MMDR
Presentation: Earlier access to medicines and medical technologies and the MMDRTGA Australia
 
TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017 TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017 TGA Australia
 
TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?TGA Australia
 
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA RegulationsEnhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations3ECompany
 
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA RegulationsEnhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations3ECompany
 
Presentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reformsPresentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reformsTGA Australia
 
Ready, Set, Oversight: How to Prepare
Ready, Set, Oversight: How to PrepareReady, Set, Oversight: How to Prepare
Ready, Set, Oversight: How to PrepareAlice Valder Curran
 
Demystifying the New EPA Hazardous Pharmaceutical Waste Rule
Demystifying the New EPA Hazardous Pharmaceutical Waste RuleDemystifying the New EPA Hazardous Pharmaceutical Waste Rule
Demystifying the New EPA Hazardous Pharmaceutical Waste RuleTriumvirate Environmental
 
Nw biotech fundamentals day 1 session 3 regulatory
Nw biotech fundamentals day 1 session 3   regulatoryNw biotech fundamentals day 1 session 3   regulatory
Nw biotech fundamentals day 1 session 3 regulatoryNicholas Weston Lawyers
 
The Regulatory Horizon
The Regulatory HorizonThe Regulatory Horizon
The Regulatory HorizonMichael Swit
 
Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...TGA Australia
 
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-Slides
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-SlidesCovered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-Slides
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-SlidesClay Willis
 
Presentation: Regulatory affairs - The Australian and International landscape
Presentation: Regulatory affairs - The Australian and International landscapePresentation: Regulatory affairs - The Australian and International landscape
Presentation: Regulatory affairs - The Australian and International landscapeTGA Australia
 
Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Canadian Cancer Survivor Network
 

Similar to The Frank R. Lautenberg Chemical Safety for the 21st Century Act (20)

Prescription Medicines MMDR Reforms
Prescription Medicines MMDR ReformsPrescription Medicines MMDR Reforms
Prescription Medicines MMDR Reforms
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
 
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?
Canada's New Drug Pricing Rules: What are the Implications for Cancer Patients?
 
Presentation: Earlier access to medicines and medical technologies and the MMDR
Presentation: Earlier access to medicines and medical technologies and the MMDRPresentation: Earlier access to medicines and medical technologies and the MMDR
Presentation: Earlier access to medicines and medical technologies and the MMDR
 
TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017 TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017
 
TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?
 
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA RegulationsEnhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
 
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA RegulationsEnhancing Chemical Management Within the Framework of Existing TSCA Regulations
Enhancing Chemical Management Within the Framework of Existing TSCA Regulations
 
Presentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reformsPresentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reforms
 
Ready, Set, Oversight: How to Prepare
Ready, Set, Oversight: How to PrepareReady, Set, Oversight: How to Prepare
Ready, Set, Oversight: How to Prepare
 
RDD 2020 Day 1 PM: Health Canada Regulatory Update
RDD 2020 Day 1 PM: Health Canada Regulatory UpdateRDD 2020 Day 1 PM: Health Canada Regulatory Update
RDD 2020 Day 1 PM: Health Canada Regulatory Update
 
Demystifying the New EPA Hazardous Pharmaceutical Waste Rule
Demystifying the New EPA Hazardous Pharmaceutical Waste RuleDemystifying the New EPA Hazardous Pharmaceutical Waste Rule
Demystifying the New EPA Hazardous Pharmaceutical Waste Rule
 
Nw biotech fundamentals day 1 session 3 regulatory
Nw biotech fundamentals day 1 session 3   regulatoryNw biotech fundamentals day 1 session 3   regulatory
Nw biotech fundamentals day 1 session 3 regulatory
 
The Regulatory Horizon
The Regulatory HorizonThe Regulatory Horizon
The Regulatory Horizon
 
Drug Approval & Reimbursement Processes
Drug Approval & Reimbursement ProcessesDrug Approval & Reimbursement Processes
Drug Approval & Reimbursement Processes
 
Barbara Cunningham: US EPA's Chemicals Management Program
Barbara Cunningham: US EPA's Chemicals Management ProgramBarbara Cunningham: US EPA's Chemicals Management Program
Barbara Cunningham: US EPA's Chemicals Management Program
 
Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...Presentation Trends in Australian and international regulation and regulatory...
Presentation Trends in Australian and international regulation and regulatory...
 
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-Slides
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-SlidesCovered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-Slides
Covered-Outpatient-Drugs-Final-Rule-Webinar-for-GP-Professionals-Slides
 
Presentation: Regulatory affairs - The Australian and International landscape
Presentation: Regulatory affairs - The Australian and International landscapePresentation: Regulatory affairs - The Australian and International landscape
Presentation: Regulatory affairs - The Australian and International landscape
 
Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?
 

Recently uploaded

VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTS
VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTSVIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTS
VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTSDr. Oliver Massmann
 
如何办理澳洲南澳大学(UniSA)毕业证学位证书
如何办理澳洲南澳大学(UniSA)毕业证学位证书如何办理澳洲南澳大学(UniSA)毕业证学位证书
如何办理澳洲南澳大学(UniSA)毕业证学位证书Fir L
 
Why Every Business Should Invest in a Social Media Fraud Analyst.pdf
Why Every Business Should Invest in a Social Media Fraud Analyst.pdfWhy Every Business Should Invest in a Social Media Fraud Analyst.pdf
Why Every Business Should Invest in a Social Media Fraud Analyst.pdfMilind Agarwal
 
Understanding Social Media Bullying: Legal Implications and Challenges
Understanding Social Media Bullying: Legal Implications and ChallengesUnderstanding Social Media Bullying: Legal Implications and Challenges
Understanding Social Media Bullying: Legal Implications and ChallengesFinlaw Associates
 
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书Fs Las
 
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual serviceanilsa9823
 
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书如何办理(Lincoln文凭证书)林肯大学毕业证学位证书
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书Fs Las
 
How You Can Get a Turkish Digital Nomad Visa
How You Can Get a Turkish Digital Nomad VisaHow You Can Get a Turkish Digital Nomad Visa
How You Can Get a Turkish Digital Nomad VisaBridgeWest.eu
 
一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书E LSS
 
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书FS LS
 
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书Fir L
 
THE FACTORIES ACT,1948 (2).pptx labour
THE FACTORIES ACT,1948 (2).pptx   labourTHE FACTORIES ACT,1948 (2).pptx   labour
THE FACTORIES ACT,1948 (2).pptx labourBhavikaGholap1
 
如何办理纽约州立大学石溪分校毕业证学位证书
 如何办理纽约州立大学石溪分校毕业证学位证书 如何办理纽约州立大学石溪分校毕业证学位证书
如何办理纽约州立大学石溪分校毕业证学位证书Fir sss
 
The Active Management Value Ratio: The New Science of Benchmarking Investment...
The Active Management Value Ratio: The New Science of Benchmarking Investment...The Active Management Value Ratio: The New Science of Benchmarking Investment...
The Active Management Value Ratio: The New Science of Benchmarking Investment...James Watkins, III JD CFP®
 
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top BoutiqueAndrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top BoutiqueSkyLaw Professional Corporation
 
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书Fir L
 
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书srst S
 

Recently uploaded (20)

VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTS
VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTSVIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTS
VIETNAM – LATEST GUIDE TO CONTRACT MANUFACTURING AND TOLLING AGREEMENTS
 
如何办理澳洲南澳大学(UniSA)毕业证学位证书
如何办理澳洲南澳大学(UniSA)毕业证学位证书如何办理澳洲南澳大学(UniSA)毕业证学位证书
如何办理澳洲南澳大学(UniSA)毕业证学位证书
 
Why Every Business Should Invest in a Social Media Fraud Analyst.pdf
Why Every Business Should Invest in a Social Media Fraud Analyst.pdfWhy Every Business Should Invest in a Social Media Fraud Analyst.pdf
Why Every Business Should Invest in a Social Media Fraud Analyst.pdf
 
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
 
Understanding Social Media Bullying: Legal Implications and Challenges
Understanding Social Media Bullying: Legal Implications and ChallengesUnderstanding Social Media Bullying: Legal Implications and Challenges
Understanding Social Media Bullying: Legal Implications and Challenges
 
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书
如何办理(SFSta文凭证书)美国旧金山州立大学毕业证学位证书
 
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Singar Nagar Lucknow best sexual service
 
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书如何办理(Lincoln文凭证书)林肯大学毕业证学位证书
如何办理(Lincoln文凭证书)林肯大学毕业证学位证书
 
How You Can Get a Turkish Digital Nomad Visa
How You Can Get a Turkish Digital Nomad VisaHow You Can Get a Turkish Digital Nomad Visa
How You Can Get a Turkish Digital Nomad Visa
 
一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书
 
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书
如何办理密德萨斯大学毕业证(本硕)Middlesex学位证书
 
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书
如何办理普利茅斯大学毕业证(本硕)Plymouth学位证书
 
THE FACTORIES ACT,1948 (2).pptx labour
THE FACTORIES ACT,1948 (2).pptx   labourTHE FACTORIES ACT,1948 (2).pptx   labour
THE FACTORIES ACT,1948 (2).pptx labour
 
如何办理纽约州立大学石溪分校毕业证学位证书
 如何办理纽约州立大学石溪分校毕业证学位证书 如何办理纽约州立大学石溪分校毕业证学位证书
如何办理纽约州立大学石溪分校毕业证学位证书
 
Russian Call Girls Rohini Sector 7 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 7 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...Russian Call Girls Rohini Sector 7 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 7 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
 
The Active Management Value Ratio: The New Science of Benchmarking Investment...
The Active Management Value Ratio: The New Science of Benchmarking Investment...The Active Management Value Ratio: The New Science of Benchmarking Investment...
The Active Management Value Ratio: The New Science of Benchmarking Investment...
 
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top BoutiqueAndrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
 
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书
如何办理美国加州大学欧文分校毕业证(本硕)UCI学位证书
 
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书
如何办理(UoM毕业证书)曼彻斯特大学毕业证学位证书
 
Old Income Tax Regime Vs New Income Tax Regime
Old  Income Tax Regime Vs  New Income Tax   RegimeOld  Income Tax Regime Vs  New Income Tax   Regime
Old Income Tax Regime Vs New Income Tax Regime
 

The Frank R. Lautenberg Chemical Safety for the 21st Century Act

  • 1. The Frank R. Lautenberg Chemical Safety for the 21st Century Act Overview June 2016
  • 2. The New Law • The “Frank R. Lautenberg Chemical Safety for the 21st Century Act” was signed by the President and went into effect on June 22, 2016 • Amends and updates the Toxic Substances Control Act of 1976 • Passed by large bipartisan margins in the U.S. House and Senate • Received broad stakeholder support 2
  • 3. Major Improvements Over Current Law • Mandatory duty on EPA to evaluate existing chemicals with clear and enforceable deadlines – Old TSCA – no duty to review; no deadlines for action • Chemicals assessed against a risk-based safety standard – Old TSCA – risk-benefit balancing standard • Unreasonable risks identified in the risk evaluation must be eliminated – Old TSCA – Signficant risks might not be addressed due to cost/benefit balancing and no mandate to act • Expanded authority to more quickly require development of chemical information when needed – Old TSCA – Required lengthy rulemaking 3
  • 4. Major Improvements Over Current Law • Requires EPA to make an affirmative determination on new chemicals before entry into the marketplace – Old TSCA – new chemicals enter the market in the absence of EPA action • Requires substantiation of certain CBI claims – Old TSCA – no statutory substantiation requirements for CBI claims • New funding source (up to $25 million total in annual user fees), to be supplemented by Congressional appropriations – Old TSCA – Cap on individual user fees at $2,500, and limited fee collection authority 4
  • 5. New Chemicals • New law requires EPA to make affirmative finding on new chemicals or significant new uses of existing chemicals • Before the chemical can enter the market, EPA must find that the chemical: – “presents an unreasonable risk” and issue a 5(f) order to address such risk; – “information…is insufficient to permit a reasoned evaluation…” and issue a 5(e) order; – “may present an unreasonable risk” and issue a 5(e) order; or – is “not likely to present an unreasonable risk” and publish the determination • New law effectively resets 90-day clock for reviews underway but EPA is working to complete reviews & make determinations within the original review period. 5
  • 6. Specific Requirements Existing Chemicals • Prioritizing Chemicals for Assessment – Establish a risk-based process to identify “high” and “low” priority substances – High priority – the chemical may present an unreasonable risk of injury to health or the environment due to potential hazard and route of exposure, including to susceptible subpopulations – Low priority – the chemical use does not meet the standard for high-priority  Procedural rule required by June 2017 to establish process for prioritizing chemicals o Interim milestone – proposed rule mid-December 2016 6
  • 7. Specific Requirements Existing Chemicals • Risk Evaluation – “High priority” designation triggers mandatory risk evaluation to be completed in 3 years, with possible 6 month extension – For each risk evaluation completed, EPA must designate a new high priority chemical – Within 3.5 years, EPA must have 20 ongoing chemical risk evaluations  Procedural rule required by June 2017 to establish process for evaluating the risks of high priority chemicals o Interim Milestone – Proposed rule mid-December 2016 7
  • 8. Specific Requirements Existing Chemicals • Initial Set of Work Plan Chemical Assessments – Identify a list of 10 TSCA Work Plan chemicals and formally initiate risk evaluations by mid- December 2016 – Release the scope of each assessment by mid- June 2017 8
  • 9. Specific Requirements Existing Chemicals • Risk-Based Safety Standard – Chemicals are evaluated against a new risk-based safety standard to determine whether a chemical use poses an “unreasonable risk” • The risk determination is to be made without consideration of costs or other non-risk factors – Risks to susceptible and highly exposed populations must be considered – EPA must take risk management action to address unreasonable risks • Costs and availability of alternatives to be considered when selecting among risk management options • Exemption process for critical uses • Risk management actions must be promulgated within 2 years of completing risk evaluation, with extension of up to two additional years 9
  • 10. Specific Requirements Existing Chemicals • Manufacturer-Requested Assessment – Establishes a process for manufacturers to request that EPA evaluate specific chemicals, and pay costs as follows: • For chemicals on the TSCA Workplan, manufacturers pay 50% of costs; and • For all other chemicals, manufacturers pay 100% of costs • Manufacturer requests subject to the following limitations: – Granted at the Administrator’s discretion – Do not count toward the 20 risk evaluations EPA must have underway – Must be a minimum of 25% of ongoing reviews but no more than 50% • E.g., if EPA is evaluating 20 high priority chemicals, there could be an additional 5 to 10 industry petitioned evaluations proceeding in parallel 10
  • 11. Specific Requirements Existing Chemicals • Persistent, Bioaccumulative and Toxic Chemicals – The new law establishes fast-track process to address certain PBT chemicals already on TSCA Workplan – No risk evaluation; only a use and exposure assessment – Rules to reduce exposure to the extent practable must be proposed within 3 years of enactment and finalized 18 months later, unless a manufacturer requests a risk evaluation by Sept. 22, 2016 – Additional requirements encourage prioritization of PBTs in overall risk evaluation process 11
  • 12. Existing Chemicals • TSCA Inventory – Requires industry to report on the chemicals they manufactured or processed in previous 10 years to determine if chemicals are currently “active” in the marketplace – The chemicals on the TSCA Inventory will not change – Chemicals will be designated as “active” or “inactive” – Only “active” chemcials may be prioritized – No PMN required to move from “inactive” to “active” 12
  • 14. Specific Requirements Existing Chemicals • Ongoing Risk Management Rulemakings – For chemical uses with completed risk assessments showing unreasonable risk before June 22, 2016, Section 26 allows EPA to propose and issue final Section 6 rules consistent with those assessments – EPA anticipates issuing the following rules: • TCE use in spot cleaning and aerosol degreasing • TCE use in vapor degreasing • Methylene chloride (MC) and N-methylpyrrolidone (NMP) in paint removers 14
  • 15. Testing Authority • Provides authority to issue orders to require testing when necessary for prioritizing a chemical or conducting a risk evaluation, in addition to rulemaking • Requires development of strategic plan for promoting the development and implementation of alternative (non-animal) testing methodologies and protocols 15
  • 16. Confidential Business Information • New requirements for Confidential Business Information (CBI) will provide greater public access to critical chemical information – Manufacturers must substantiate certain CBI claims including those for chemical identity (Chem ID) for existing chemicals • All CBI claims sunset after ten years unless reasserted by the company – For new CBI claims, EPA must: • Affirmatively review all chem ID CBI claims • Screen a subset of non-chem ID CBI claims (25%) – For past CBI claims, EPA must: • Retrospectively review past chem ID claims to determine if claims are adequately substantiated. 16
  • 17. Source of Funding • Provides authority to collect fees from manufacturers and processors who: – Are required to submit test data; – Submit notification of intent to manufacture a new chemical or new use of a chemical; – Manufacture or process a chemical substance that is subject to a risk evaluation; or – Request EPA to conduct risk evaluation on an existing chemical; • General fee amounts: – EPA can set fees amounts to defray 25% of program implementation costs – Subject to annual cap of $25 million  Goal – Engage stakeholders and publish proposed rule by mid-December and final rule mid-June 2017 17
  • 18. State-Federal Partnership • Preservation of State Laws – Bill preserves state authority to act on chemical risks not acted on by EPA. – If EPA does act, the following State actions are preserved: • Actions taken before April 2016 • The implementation of other environmental laws (air, water, waste treatment, disposal, reporting, monitoring, etc.) • Co-enforcement of identical requirements and penalties that do not exceed the federal maximum • Actions on chemicals identified as low-priority by EPA 18
  • 19. State-Federal Partnership • Preemption of State Laws – If EPA’s assessment indicates that a chemical is safe, State provisions are preempted – If EPA takes final action to address a chemical’s risks, State provisions are preempted, – State Significant New Use Rules preempted if EPA imposes a comparable requirement, unless waivers or exceptions are identified. • New State action is “paused” during EPA’s risk evaluation of high priority chemicals – If EPA misses deadline for the risk evaluation, pause is lifted – If risks identified, pause is lifted and states could put new provisions in place but would be preempted on effective date of EPA’s final risk management rule – If EPA determines chemical is safe, preemption continues 19
  • 20. State-Federal Partnership • State Waivers for Preemption – States can apply to EPA for a waiver from general or pause preemption. – EPA must grant an exemption from pause preemption if: • State has enacted a statute, or proposed or finalized an administrative action, to prohibit or restrict a chemical, or • State provision meets certain criteria – EPA may grant an exemption from general preemption, through rulemaking, if specific criteria are met, including: • “Compelling conditions” that necessitate the waiver; • No undue burden on interstate commerce; and • EPA support for the State’s scientific judgment of the risk, based on best available science and weight of evidence – If EPA fails to make a decision on a state waiver within 110 day review period, the waiver is automatically granted – EPA’s grant of an exemption can be challenged in court. 20
  • 21. Other Actions • Mercury – Adds mercury compounds to export ban of elemental mercury • Publish initial list of prohibited compounds by mid-Sep – Requires that EPA publish an inventory of mercury supply, use and trade in the US • Publish by April 1, 2017 and update every 3 years • Annual Report to Congress • Review Small Business definition within 180 days • Establish a Scientific Advisory Committee by June 2017 21
  • 22. Key Milestones New Chemicals Existing Chemicals Inventory / Nomenclature CBI Other Fees Day 1 Implement for all - §6 rules under development will address new standards - Risk Assessments – will address new standards - Review CBI claims for chem ID w/in 90 days 6 Months -Publish List of 10 Risk Assessments underway for WP Chemicals -January 1st of each year – updated plan for Risk Evaluations ** Proposed rule – prioritization and evaluation Proposed rule – Active/Inactive -Determine whether review small business definition warranted -Report to Congress on Capacity to Implement **Proposed Rule 1 Year -Final Rule: Prioritization Process -Final Rule: Risk Evaluation Process (including guidance for manufacturer requests) - Publish scope of first 10 risk evaluations -Final Rule: Active/Inactive --Establish SACC **Final Rule 2 Year -Negotiated Proposed Rule – Byproduct Reporting -2½ years: Get active/inactive reports -Rules re: CBI substantiation – 2.5 years -Guidance re: generic names -Strategic Plan: Promote Alternative Test Methods -All policies, procedures, guidance needed 3 Year -3½ years -- 20 Risk Assessments underway (1/2 from WP, min) -20 Low Priorities identified -Proposed Rule – WorkPlan PBTs -Final Rule: Byproducts -3½ years: Rule to establish plan for reviewing all CBI claims for active chemical IDs 5 Year -4 ½ years – Final Rule: PBTs -Complete review of CBI claims for all active ChemIDs -Report to Congress re: implementation of plan re: Alternative Methods **Not a statutory deadline 22
  • 23. For More Information: https://www.epa.gov/assessing-and-managing-chemicals- under-tsca/frank-r-lautenberg-chemical-safety-21st- century-act Contact EPA at: https://www.epa.gov/assessing-and-managing-chemicals- under-tsca/forms/assessing-and-managing-chemicals- under-tsca 23